Company News

Exclusive Option Agreement for NXP001 in Oncology

Nuformix a pharmaceutical development company focused on unlocking the therapeutic potential and value of knowndrugs to develop novel medicines to provide enhanced benefit, announces it has signed an exclusiveoption agreement with Oxilio Ltd (“Oxilio”) Read more

Related stories

Read More

Park members took a break from their desks this week to join a free Willow Weaving workshop, delivered in partnership ...

Read More

Tucked inside the Trinity Centre is one of the Park’s most unexpected high-performance environments: a Brazilian Jiu-Jitsu academy run by Leo ...

Read More

Cambridge Science Centre, based at the Park’s Trinity Centre, has unveiled a bold new five-year strategy designed to help secure ...

Want to see your news featured here? Contact the team and let’s spread the word.